(-0.31%) 5 020.04 points
(0.27%) 37 917 points
(-0.40%) 15 595 points
(-3.34%) $79.19
(-2.46%) $1.942
(0.58%) $2 316.30
(0.30%) $26.73
(0.89%) $956.65
(0.00%) $0.937
(-0.02%) $11.09
(0.11%) $0.801
(-0.48%) $93.00
1.85% HKD 0.550
Live Chart Being Loaded With Signals
Kingworld Medicines Group Limited, an investment holding company, distributes branded imported pharmaceutical and healthcare products. The company also supplies pharmaceutical, healthcare, general foodstuffs, and medical products...
Stats | |
---|---|
Tagesvolumen | 1.21M |
Durchschnittsvolumen | 218 413 |
Marktkapitalisierung | 325.85M |
EPS | HKD0 ( 2023-04-21 ) |
Nächstes Ertragsdatum | ( HKD0 ) 2024-05-29 |
Last Dividend | HKD0.0247 ( 2023-06-01 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 7.86 |
ATR14 | HKD0.00800 (1.45%) |
Kingworld Medicines Group Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Kingworld Medicines Group Finanzdaten
Annual | 2023 |
Umsatz: | HKD1.08B |
Bruttogewinn: | HKD280.67M (26.02 %) |
EPS: | HKD0.0644 |
FY | 2023 |
Umsatz: | HKD1.08B |
Bruttogewinn: | HKD280.67M (26.02 %) |
EPS: | HKD0.0644 |
FY | 2022 |
Umsatz: | HKD957.70M |
Bruttogewinn: | HKD277.63M (28.99 %) |
EPS: | HKD0.0718 |
FY | 2021 |
Umsatz: | HKD847.39M |
Bruttogewinn: | HKD263.60M (31.11 %) |
EPS: | HKD0.0490 |
Financial Reports:
No articles found.
Kingworld Medicines Group Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.0247 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0371 | 2011-05-16 |
Last Dividend | HKD0.0247 | 2023-06-01 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | HKD0.388 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.89 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.84 | |
Div. Directional Score | 7.48 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
2380.HK | Ex Dividend Junior | 2023-06-12 | Annually | 0 | 0.00% | |
1361.HK | Ex Dividend Knight | 2023-08-28 | Annually | 0 | 0.00% | |
0423.HK | Ex Dividend Junior | 2023-08-10 | Semi-Annually | 0 | 0.00% | |
6808.HK | Ex Dividend Junior | 2023-08-22 | Annually | 0 | 0.00% | |
1913.HK | Ex Dividend Junior | 2023-05-03 | Annually | 0 | 0.00% | |
0945.HK | Ex Dividend King | 2023-08-22 | Quarterly | 0 | 0.00% | |
0071.HK | Ex Dividend Knight | 2023-09-25 | Semi-Annually | 0 | 0.00% | |
2899.HK | Ex Dividend Knight | 2023-05-30 | Annually | 0 | 0.00% | |
1513.HK | Ex Dividend Knight | 2023-07-04 | Annually | 0 | 0.00% | |
0560.HK | Ex Dividend Junior | 2023-06-26 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0353 | 1.500 | 9.29 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0285 | 1.200 | 9.05 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0591 | 1.500 | -0.454 | -0.681 | [0.1 - 1] |
payoutRatioTTM | 0.355 | -1.000 | 6.45 | -6.45 | [0 - 1] |
currentRatioTTM | 1.270 | 0.800 | 8.65 | 6.92 | [1 - 3] |
quickRatioTTM | 0.748 | 0.800 | -0.308 | -0.246 | [0.8 - 2.5] |
cashRatioTTM | 0.375 | 1.500 | 9.03 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.265 | -1.500 | 5.58 | -8.38 | [0 - 0.6] |
interestCoverageTTM | 7.35 | 1.000 | 8.39 | 8.39 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.149 | 2.00 | 9.95 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.00234 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.573 | -1.500 | 7.71 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.260 | 1.000 | 9.00 | 9.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0729 | 1.000 | -0.541 | -0.541 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.250 | 1.000 | 9.72 | 9.72 | [0.2 - 2] |
assetTurnoverTTM | 0.806 | 0.800 | 7.96 | 6.37 | [0.5 - 2] |
Total Score | 11.12 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 7.79 | 1.000 | 9.31 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0591 | 2.50 | -0.292 | -0.681 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.00234 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.95 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.149 | 2.00 | 9.95 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.355 | 1.500 | 6.45 | -6.45 | [0 - 1] |
pegRatioTTM | -0.438 | 1.500 | -6.25 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0823 | 1.000 | -0.443 | 0 | [0.1 - 0.5] |
Total Score | 3.84 |
Kingworld Medicines Group
Kingworld Medicines Group Limited, an investment holding company, distributes branded imported pharmaceutical and healthcare products. The company also supplies pharmaceutical, healthcare, general foodstuffs, and medical products. It offers products for various functional categories, such as cough and phlegm relieving, gastrointestinal, vitamin, orthopedics, cardiovascular, influenza, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, Kawai Product Range, Flying Eagle Wood Lok Medicated Oil, Kyushin Pill, and Mentholatum Product Range brands. The company also manufactures and sells electrotherapeutic and physiotherapeutic devices, and general medical examination devices. It serves in the People's Republic of China, Hong Kong, the United States, the United Kingdom, Germany, Italy, Spain, Mexico, and internationally. The company was founded in 1996 and is headquartered in Shenzhen, the People's Republic of China.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.